All News

On Monday, days after he was sworn in as the new commissioner of the FDA, Scott Gottlieb, MD, delivered a speech to staff acknowledging the substantial challenges the agency must tackle, but expressing an optimistic drive to “fulfill FDA’s special mission.”

A new study in JAMA has found that patient-reported pain satisfaction scores on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys are not associated with rates of opioid prescribing after surgery.

A new paper in Orphanet Journal of Rare Diseases outlines a new pipeline for identifying opportunities to develop therapies for rare diseases that do not have treatments.

Full results of the CANVAS trial are expected to be released in June at the American Diabetes Association.

The effort to address healthcare disparities in a wealthy state comes as Medicaid is at a crossroads. A recent report found the $15.5 billion program falls short in key areas, and the governor is trying to extract money from Horizon's Medicaid reserves, set aside to pay claims, for an addiction program.

There are conflicting guidelines regarding when to screen cholesterol levels in young adults. A new study aims to clarify at what age asymptomatic individuals should be screened to calculate their elevated risk of developing atherosclerotic cardiovascular disease.

As Medicare has no limit capping out-of-pocket costs and supplemental coverage can be expensive, many beneficiaries are spending significant portions of their income out-of-pocket on medical care or premiums, according to a recent report published by the Commonwealth Fund.

Exercise is important for wellness and can also improve patient outcomes. The question remains: who should take the lead in recommending an exercise routine for patients with cancer?

A new blood-based diagnostic test (IsoPSA) for prostate cancer that evaluates structural changes in prostate-specific antigen could reduce unnecessary biopsies and identify the right patients that need treatment.

Pressure is mounting for Congress or President Trump to do something about rising drug costs, as polls show there is broad support for government intervention on this issue.

According to a new study published in JAMA Internal Medicine, black individuals living in more racially segregated neighborhoods tended to have higher blood pressure, while those who moved to less segregated areas saw their blood pressure decrease.

The study found that the more classes the participants took, the more weight they lost. The DPP is set to begin in Medicare in January 2018.

A new study indicates that a technology-based intervention could help patients make informed decisions about cancer screening.

If all children engaged in CDC-recommended levels of physical activity, the resulting decreases in obesity could save up to $51.5 billion in direct medical costs and $69 billion in lost productivity each year.

While it remains to be seen how the Trump administration deals with healthcare fraud, preventing fraudulent practices within your organization should be a priority-unless you want to be held personally liable.

Only 20% of a person’s health can be attributed to healthcare. What happens outside the hospital and clinic doors is far more important in determining how healthy a person or population will be.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Twenty-five percent of patients receiving neoadjuvant chemotherapy treatment for ovarian cancer develop venous thromboembolism, according to a new study published in the journal Obstetrics & Gynecology.

The attackers appear to have used a vulnerability developed by the National Security Agency, which was stolen and posted online.

The meta-analysis covers 92 studies from 16 countries, and includes 3.2 million patients.

The integrated health plan has a strategy to combat the effects of isolation and its effects, which increase the risk of Alzheimer's disease, obesity, and hospital readmissions.

This week, the top managed care stories included the Senate began working on its own Obamacare replacement bill; Scott Gottlieb, MD, was confirmed as FDA commissioner; and coverage from Digestive Disease Week.

As we near the first anniversary of the Oncology Care Model, CMS' bundled payment program for oncology, explore why practices are participating and the challenges they have faced over the past 9 months.

Tumor response rate and progression-free survival were the benchmarks that helped pembrolizumab (Keytruda) gain accelerated approval as first-line treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), in combination with chemotherapy.

A cohort study of TRICARE patients found that those who began to use statins were more likely to be diagnosed with a back disorder.

The creator of the compromise that pushed the Obamacare replacement past its first hurdle withstood hours of jeers from angry constituents, as he tried to present the nuances of a plan to shore up the individual health insurance market.